title: Methylene blue chromoendoscopy for detection of short-segment Barrett's esophagus.
abstract: BACKGROUND
  The yield of intestinal metaplasia (IM) with randomly obtained biopsy specimens in patients with short lengths of columnar-appearing mucosa in the distal esophagus is low (30%-50%). Vital staining would be beneficial if it identified more patients with short-segment Barrett's esophagus (SSBE). Our aim was to compare the confirmation of IM in patients with suspected SSBE (columnar-appearing mucosa <3 cm in length) by using methylene blue (MB)-directed versus random biopsies.
  
  
  METHODS
  Consecutive patients undergoing EGD in whom columnar-appearing mucosa less than 3 cm in length was visualized underwent MB staining. Stained areas within suspected SSBE segments were targeted for biopsies. All biopsy specimens were stained with H & E with alcian blue at pH 2.5 and evaluated by a single pathologist. A historical control group (different from patients undergoing MB staining) consisted of patients with less than 3 cm of columnar-appearing mucosa in whom biopsy specimens were obtained randomly without MB staining.
  
  
  RESULTS
  The MB group included 75 patients (mean age 63.8 +/- 10.9 years) with a mean length of columnar-appearing mucosa of 1.2 cm (range 0.5-2.5 cm). The control group included 83 patients (mean age 60.5 +/- 12.9 years) with a mean length of columnar-appearing mucosa of 1.16 cm (range 0.5-2.5 cm). IM (i.e., confirmed SSBE) was detected in 61% of the MB group versus 42% of the control group (p = 0.0237). Patients in the MB group required significantly fewer biopsies (4.3 +/- 1.5 vs. 5.1 +/- 12.3, p = 0.0162). Confirmation of IM by length was as follows: less than 1 cm (irregular Z line), MB 17.4% versus control 25% (p = 0.73); 1 to less than 2 cm, MB 77% versus control 45% (p = 0.03); 2 to less than 3 cm, MB 90% versus control 58% (p = 0.02).
  
  
  CONCLUSIONS
  MB chromoendoscopy significantly increases the detection of IM and requires fewer biopsies in patients with suspected SSBE with greater than 1 cm of columnar-appearing mucosa. It does not appear to be beneficial in patients with irregular Z lines (<1 cm).
authors.affiliation: Division of Gastroenterology, Department of Pathology and Preventive Medicine, University of Kansas and Veterans Affairs Medical Center, Kansas City, Missouri 64128-2295, USA.
authors.forename: P
authors.initials: P
authors.lastname: Sharma
authors.forename: M
authors.initials: M
authors.lastname: Topalovski
authors.forename: M S
authors.initials: MS
authors.lastname: Mayo
authors.forename: A P
authors.initials: AP
authors.lastname: Weston
mesh_terms: D001471:Barrett Esophagus / Q000473:pathology*; D001706:Biopsy / Q000379:methods*; D016022:Case-Control Studies; D016145:Endoscopy, Digestive System; D004947:Esophagus / Q000473:pathology; D006801:Humans; D008297:Male; D008751:Methylene Blue; D008875:Middle Aged; D013194:Staining and Labeling
chemical_list: D008751:Methylene Blue